Guangdong Lifestrong Pharmacy Co. Ltd. (301111) - Total Assets

Latest as of March 2026: CN¥897.92 Million CNY ≈ $131.39 Million USD

Based on the latest financial reports, Guangdong Lifestrong Pharmacy Co. Ltd. (301111) holds total assets worth CN¥897.92 Million CNY (≈ $131.39 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Guangdong Lifestrong Pharmacy Co. Ltd. - Total Assets Trend (2017–2025)

This chart illustrates how Guangdong Lifestrong Pharmacy Co. Ltd.'s total assets have evolved over time, based on quarterly financial data. Also see Guangdong Lifestrong Pharmacy Co. Ltd. stock valuation for the company's overall valuation and market capitalisation.

Guangdong Lifestrong Pharmacy Co. Ltd. - Asset Composition Analysis

Current Asset Composition (December 2025)

Guangdong Lifestrong Pharmacy Co. Ltd.'s total assets of CN¥897.92 Million consist of 78.4% current assets and 21.6% non-current assets. Review Guangdong Lifestrong Pharmacy Co. Ltd. (301111) financial obligations to assess the company's total debt and financial obligations.

Asset Category Amount (CNY) % of Total Assets
Cash & Equivalents CN¥0.00 16.0%
Accounts Receivable CN¥76.60 Million 8.6%
Inventory CN¥77.31 Million 8.7%
Property, Plant & Equipment CN¥0.00 0.0%
Intangible Assets CN¥29.52 Million 3.3%
Goodwill CN¥7.32 Million 0.8%

Asset Composition Trend (2017–2025)

This chart illustrates how Guangdong Lifestrong Pharmacy Co. Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See 301111 stock price for real-time trading data and today's change.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Guangdong Lifestrong Pharmacy Co. Ltd.'s current assets represent 78.4% of total assets in 2025, an increase from 74.5% in 2017.
  • Cash Position: Cash and equivalents constituted 16.0% of total assets in 2025, down from 33.8% in 2017.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, unchanged from 3.0% in 2017.
  • Asset Diversification: The largest asset category is inventory at 8.7% of total assets.

Guangdong Lifestrong Pharmacy Co. Ltd. Competitors by Total Assets

Key competitors of Guangdong Lifestrong Pharmacy Co. Ltd. based on total assets are shown below.

Company Country Total Assets
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
Germany €1.60 Trillion
GALDERMA GROUP AG
NYSE:GALDY
USA $13.39 Billion
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
USA $15.42 Trillion
Beijing Tongrentang Co Ltd
SHG:600085
China CN¥31.82 Billion
Takeda Pharmaceutical Company Limited
F:TKDA
Germany €15.41 Trillion
Changchun High & New Technology Industries Group Inc
SHE:000661
China CN¥30.77 Billion
Neuland Laboratories Limited
NSE:NEULANDLAB
India Rs29.30 Billion
China Resources Double-Crane Pharmaceutical Co Ltd
SHG:600062
China CN¥17.01 Billion

Guangdong Lifestrong Pharmacy Co. Ltd. - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 6.48 5.61 4.87
Quick Ratio 5.77 4.53 4.04
Cash Ratio 0.00 0.00 0.00
Working Capital CN¥588.96 Million CN¥420.73 Million CN¥250.65 Million

Guangdong Lifestrong Pharmacy Co. Ltd. - Advanced Valuation Insights

This section examines the relationship between Guangdong Lifestrong Pharmacy Co. Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 4.26
Latest Market Cap to Assets Ratio 0.55
Asset Growth Rate (YoY) -4.2%
Total Assets CN¥894.13 Million
Market Capitalization $492.38 Million USD

Valuation Analysis

Below Book Valuation: The market values Guangdong Lifestrong Pharmacy Co. Ltd.'s assets below their book value (0.55x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Guangdong Lifestrong Pharmacy Co. Ltd.'s assets decreased by 4.2% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Guangdong Lifestrong Pharmacy Co. Ltd. (2017–2025)

The table below shows the annual total assets of Guangdong Lifestrong Pharmacy Co. Ltd. from 2017 to 2025.

Year Total Assets Change
2025-12-31 CN¥894.13 Million
≈ $130.84 Million
-4.18%
2024-12-31 CN¥933.17 Million
≈ $136.55 Million
+9.07%
2023-12-31 CN¥855.54 Million
≈ $125.19 Million
-0.18%
2022-12-31 CN¥857.06 Million
≈ $125.42 Million
+3.74%
2021-12-31 CN¥826.20 Million
≈ $120.90 Million
+115.28%
2020-12-31 CN¥383.78 Million
≈ $56.16 Million
+17.99%
2019-12-31 CN¥325.26 Million
≈ $47.60 Million
+9.29%
2018-12-31 CN¥297.61 Million
≈ $43.55 Million
+5.94%
2017-12-31 CN¥280.91 Million
≈ $41.11 Million
--

About Guangdong Lifestrong Pharmacy Co. Ltd.

SHE:301111 China Drug Manufacturers - Specialty & Generic
Market Cap
$492.38 Million
CN¥3.36 Billion CNY
Market Cap Rank
#12346 Global
#3562 in China
Share Price
CN¥21.03
Change (1 day)
+2.99%
52-Week Range
CN¥15.51 - CN¥30.31
All Time High
CN¥56.05
About

Guangdong Lifestrong Pharmacy Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products. It operates through Medical Services and Health Management; and Health Consumer Products segments. The company produces tablets, hard capsules, injections, and pills, and other related products. It also offers respiratory, pediatric, gynecology, urinary, and nutrition and… Read more